Ranking position of feature importance for each cluster in the pre-vaccination period. by Jéssica Villar (21453137)

SHAP Values per cluster in the pre-vaccination period show each feature’s importance on COVID-19 mortality. by Jéssica Villar (21453137)

SHAP Values per cluster in the post-vaccination period show each feature’s importance on COVID-19 mortality. by Jéssica Villar (21453137)

GRADE judgements. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Basic characteristics of the included studies. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

The data of meta-analysis. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Risk of bias. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Overall risk of bias assessment. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Funnel plot of VO_2Peak inclusion studies. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Analysis of subgroups. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Key Resources. by Jeffrey Chin (22538086)

“…Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to <i>Mtb</i> infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, <i>Listeria monocytogenes</i>, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. …”

Tax1bp1-deficiency reduces autophagy flux. by Jeffrey Chin (22538086)

“…Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to <i>Mtb</i> infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, <i>Listeria monocytogenes</i>, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. …”

Characteristics of children in the study. by Shijie Yu (511369)

“…Compared with emmetropic children, myopic children had a smaller proportion of problems with self-care and a larger proportion of problems with pain/discomfort and anxiety/depression. …”

Case Fatality Ratio Differences. by Mwandida Kamba Afuleni (20917902)

Study data. by Jie Liu (15128)

“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”

Summary of clinical outcomes after 9 months. by Jie Liu (15128)

“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”

Approval by the research ethics committee. by Jie Liu (15128)

“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”

Risk Illustration. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”

Predictors of SCD. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”

Clinical outcomes. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”